Daniëlle Vugts

DR., (Principal Investigator)

20032024

Research activity per year

Network

Iris Miedema

Person: Academic

Henk Dekker

Person: Academic, Administrative

Lothar Schwarte

Person: Academic

Esther Hulleman

Person: Academic

Ezgi Ulas

Person: Academic

Mariska Verlaan

  • VU University Medical Center
  • VU Medical Center

External person

Esther J. M. Kooijman

  • VU University Medical Center
  • VU Medisch Centrum
  • VU Medical Center

External person

Romano V.A. Orru

  • VU University
  • Vrije Universiteit Amsterdam

External person

Frans J.J. De Kanter

  • Vrije Universiteit Amsterdam

External person

M. Schreurs

  • Vrije Universiteit Amsterdam

External person

Maxime Schreurs

  • VU Medical Center

External person

Marinus B. Groen

  • Vrije Universiteit Amsterdam

External person

Rob F. Schmitz

  • Vrije Universiteit Amsterdam

External person

Esther Kooijman

  • VU University Medical Center

External person

Jan Passchier

  • VU University Medical Centre
  • Erasmus Universiteit Rotterdam
  • University Medical Center Groningen
  • University of Groningen
  • Invicro

External person

Wim J. G. Oyen

  • Radboud University Nijmegen
  • Institute of Cancer Research
  • European Organisation for Research and Treatment of Cancer Data Center
  • Radboud University Medical Center
  • Royal Marsden NHS Foundation Trust
  • Department of Obstetrics and Gynaecology

External person

Ivan Penuelas

  • University of Navarra

External person

Claudia Sewing

  • Vrije Universiteit Amsterdam
  • Location Radionuclidecenter

External person

Phillip Elsinga

  • University of Groningen

External person

Matteo Zanda

  • University of Aberdeen
  • Loughborough University
  • National Research Council of Italy

External person

Qizhi Hu

  • Cristal Therapeutics

External person

Xiang-Guo Li

  • University of Turku
  • Åbo Akademi University
  • Turku PET-center

External person

Berlinda J. de Wit-van der Veen

  • Netherlands Cancer Institute

External person

Thomas L. Mindt

  • Ludwig Boltzmann Institute
  • Swiss Federal Institute of Technology
  • Medical University of Vienna
  • University of Vienna

External person

Ron H. J. Mathijssen

  • Erasmus Universiteit Rotterdam

External person

B. Bang-Andersen

  • H. Lundbeck A/S

External person

Clemens Decristoforo

  • Universitaetsklinikum fur Nuclearmedizin

External person

Adrienne H. Brouwers

  • University Medical Center Groningen
  • University Medical Center Groningen, Centre for Revalidation (Beatrix Children's Hospital)
  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University of Groningen
  • Department of Obstetrics and Gynaecology

External person

Jessica E. Wijngaarden

  • Vrije Universiteit Amsterdam
  • Amsterdam UMC

External person

A. Asuni

  • H. Lundbeck A/S

External person

W. Hayes

  • Bristol-Myers Squibb

External person

Tapan K. Nayak

  • F. Hoffmann-La Roche AG

External person

P. Flamen

  • KU Leuven

External person

M. Stigter-van Walsum

  • VU Medisch Centrum

External person

I. Mes

  • Vrije Universiteit Amsterdam

External person

Wasfi Al-Azzam

  • GSK, 19426 Collegeville, United States

External person

Gilles Gasser

  • University of Zurich
  • École nationale supérieure de chimie de Paris

External person

Eelco Ruijter

  • Vrije Universiteit Amsterdam

External person

Irene V. J. Feiner

  • CIC biomaGUNE
  • Medical University of Vienna

External person

Ricardo Vos

  • VU University Medical Center
  • Amsterdam UMC

External person

Michael Kassiou

  • University of Sydney

External person

Allan Jensen

  • Danish Cancer Society

External person

Jun Toyohara

  • Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology

External person

R. Smith

  • Bristol-Myers Squibb

External person

Henri N. J. M. Greuter

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Rolf Grempler

  • Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany
  • Boehringer Ingelheim GmbH

External person

Samuel J. Bonacorsi

  • Bristol-Myers Squibb

External person

Joseph Cowell

  • École nationale supérieure de chimie de Paris

External person

Ewoudt M. W. van de Garde

  • St. Antonius Ziekenhuis
  • Utrecht University

External person

Uta Funke

  • VU University Medical Center
  • BV Cyclotron VU

External person

P. Morin

  • Bristol-Myers Squibb

External person

Philippe Aftimos

  • Université libre de Bruxelles

External person

Mansoor Chishty

  • Pharmidex Pharmaceutical Services Ltd.

External person

Oskar Middel

  • Norwegian University of Science and Technology

External person

Mats Bergstrom

  • GlaxoSmithKline

External person

Aleksandra Pekošak

  • VU University Medical Center
  • Vrije Universiteit Amsterdam
  • Massachusetts General Hospital
  • Harvard University
  • VU Medisch Centrum

External person

Thomas E. Wuensche

  • Vrije Universiteit (VU) Amsterdam and VU Medical Center

External person

Aniek J G Even

  • Maastricht University

External person

Jordi Llop

  • CIC biomaGUNE
  • CIBER - Center for Biomedical Research Network

External person

A. Jensen

  • H. Lundbeck A/S

External person

Martin Behe

  • Paul Scherrer Institute

External person

Mohammed Al-Qahtani

  • Alfaisal University

External person

Herman Gill

  • Genentech Incorporated

External person

Lioe-Fee de Geus-Oei

  • Leiden University
  • University of Twente

External person

Twan Lammers

  • Institute for Experimental Molecular Imaging, Aachen, Germany

External person

Marc C. Huisman

  • Amsterdam UMC - Vrije Universiteit Amsterdam

External person

Sean Zhang

  • GSK, 19426 Collegeville, United States

External person

Klaus Kopka

  • German Cancer Research Center
  • University Hospital Munster
  • Helmholtz-Zentrum Dresden-Rossendorf

External person

M. Paesmans

  • Université libre de Bruxelles

External person

Wouter van Elmpt

  • Maastricht University

External person

S. Christensen

  • H. Lundbeck A/S

External person

Jan Marik

  • Genentech Incorporated

External person

E. Johanna L. Stéen

  • Vrije Universiteit Amsterdam

External person

Cristianne Rijcken

  • Cristal Therapeutics

External person

Jose Saro

  • Roche Innovation Center Zurich
  • Roche Innovation Centre

External person

Manoe M. Koningstein

  • Vrije Universiteit Amsterdam

External person

Robert H. Mach

  • University of Pennsylvania

External person

Martin Lutz

  • Vrije Universiteit Amsterdam
  • Utrecht University

External person

Frank Hoebers

  • Maastricht University

External person

Bart Janssen

  • Heidelberg University

External person

Kanar Al-Mafraji

  • Vrije Universiteit Amsterdam

External person

Suzanne C van Es

  • University of Groningen

External person

Anthony L. Spek

  • Vrije Universiteit Amsterdam
  • Utrecht University

External person

S. Vergo

  • H. Lundbeck A/S

External person

Sergio Dall'Angelo

  • University of Aberdeen

External person

Peter J. H. Scott

  • University of Michigan, Ann Arbor

External person

Sergio Todde

  • University of Milan - Bicocca

External person

Marianne Patt

  • Leipzig University

External person

Giuseppe Carlucci

  • University of California at Los Angeles

External person

Ana Rey

  • Universidad de la República

External person

Luka Rejc

  • University of Ljubljana
  • CIC biomaGUNE

External person

Florian Heil

  • Roche Innovation Center Munich

External person

James O'Brien-Brown

  • University of Sydney

External person

Philippe Lambin

  • Maastricht University
  • KU Leuven

External person

E. G. E. de Vries

  • University of Groningen

External person

Gerben J.C. Zwezerijnen

  • Vrije Universiteit Amsterdam

External person

Stefan Evers

  • Roche Innovation Center Zurich
  • Roche Innovation Centre

External person

V. Tadino

  • ORA Neptis

External person

Guy Bormans

  • KU Leuven

External person

L. Helboe

  • H. Lundbeck A/S

External person

Jean J.L. Tessier

  • F. Hoffmann-La Roche AG

External person

Jordi Pedragosa

  • August Pi i Sunyer Biomedical Research Institute

External person

D. G. J. Linders

  • Leiden University

External person

Do-Youn Oh

  • Seoul National University

External person

Hans-Jurgen Wester

  • Technical University of Munich

External person

Denise E. Hilling

  • Leiden University

External person

Shane M. Wilkinson

  • University of Sydney
  • Leeds Teaching Hospitals NHS Trust

External person

Martine Stihle

  • F. Hoffmann-La Roche AG

External person

Veena Vincent

  • GSK, 19426 Collegeville, United States

External person

Gerhard Wikström

  • Uppsala University

External person

Stuart P. McCluskey

  • Invicro LLC, London, UK

External person

Peter Brünker

  • Roche Innovation Center Zurich

External person

Jin Young Chai

  • Sogang University

External person

Neil Vasdev

  • Massachusetts General Hospital
  • Harvard University
  • Newcastle upon Tyne Hospitals NHS Foundation Trust

External person

P. Aftimos

  • Université libre de Bruxelles

External person

Philip H. Elsinga

  • University of Groningen, University Medical Center Groningen
  • University Medical Center Groningen
  • University of Groningen

External person

Wim E. Hennink

  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Netherlands
  • Utrecht University

External person

Leanne Stokes

  • university of east anglia

External person

E. Boon

  • Radboud University Nijmegen

External person

Robert L. Janiczek

  • GlaxoSmithKline

External person

C. J.F. Rijcken

  • Utrecht University
  • Cristal Therapeutics

External person

Halil Aktas

  • Vrije Universiteit Amsterdam

External person

Angel M. Carcaboso

  • Hospital Sant Joan de Déu

External person

Simon R. Cherry

  • University of California, Davis

External person

Linda M. Velasquez

  • Bristol-Myers Squibb

External person

Aurélie Doméné

  • Université de Tours

External person

Johan Wiegers

  • University of Groningen

External person

Monica Piras

  • University of Aberdeen

External person

A. L. Vahrmeijer

  • Department of Surgery, Leiden, Netherlands
  • Leiden University

External person

Johan Van Den Hoek

  • Department of Radiology and Nuclear Medicine
  • VU University Medical Centre

External person

Lars Veum

  • Delft University of Technology

External person

Barbara Klein

  • Paracelsus Private Medical University

External person

Martine Piccart

  • Université libre de Bruxelles

External person

Louise Cookson

  • GlaxoSmithKline

External person

Roy I Lalisang

  • Maastricht University

External person

David E. Hibbs

  • University of Sydney

External person

Ernesto Guarin

  • F. Hoffmann-La Roche AG

External person

S.C. van Es

  • University of Groningen

External person

Kepa Zamacola

  • CIC biomaGUNE

External person

Giovanna Pepe

  • International Centre for Rural Health of the San Paolo Hospital

External person

Marie Brandt

  • Medical University of Vienna

External person

T.K. Nayak

  • F. Hoffmann-La Roche AG

External person

Christian Klein

  • Roche Innovation Center Zurich

External person

Eric Berg

  • University of California, Davis

External person

Karen Zwanenpoel

  • Transplant Surgery

External person

Andres Kaalep

  • North Estonia Medical Centre Foundation

External person

Gunnar Antoni

  • Uppsala University

External person

Maija Hollmén

  • University of Turku

External person

Scott D. Solomon

  • Harvard University

External person

Margot E.T. Tesselaar

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

Melissa L. Barron

  • University of Sydney

External person

Javier Garcia-Corbacho

  • Hospital Clinic de Barcelona
  • University of Barcelona

External person

Ignacio Melero

  • University of Navarra

External person

Bas Groenendaal

  • Vrije Universiteit Amsterdam

External person

Dirk de Ruysscher

  • KU Leuven
  • Maastricht University

External person

Mark J.M. Vlaar

  • Vrije Universiteit Amsterdam

External person

Mabrouk Elgadi

  • Boehringer Ingelheim Pharmaceuticals

External person

Esther Kooijman

  • VU University

External person

Wouter V. Vogel

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

Sebastian Neumann

  • F. Hoffmann-La Roche AG

External person

Alessandro Villa

  • Center of Excellence on Neurodegenerative Diseases
  • University of Milan

External person

C. Roth

  • Vrije Universiteit Amsterdam

External person

Hendrik-Tobias Arkenau

  • Sarah Cannon Research Institute SCRI UK

External person

Armin Sepp

  • GlaxoSmithKline

External person

Surachet Imlimthan

  • University of Helsinki

External person

Ahmad Awada

  • Université libre de Bruxelles

External person

Patrick Pauwels

  • University of Antwerp

External person

Vesa Oikonen

  • University of Turku

External person

Pauline A. Lang

  • University of Helsinki

External person

Natasha Shalina Rajani Bidesi

  • University of Copenhagen

External person

Tuula Tolvanen

  • University of Turku

External person

Marta A. Ważyńska

  • University of Groningen

External person

Alejandro Perez Pitarch

  • Boehringer Ingelheim Pharma GmbH & Co. KG Biberach

External person

Silvio Aime

  • University of Turin

External person

Ashutosh Wechalekar

  • Great Ormond St Hospital for Children NHS Trust

External person

Adriana Maggi

  • Center of Excellence on Neurodegenerative Diseases
  • University of Milan

External person

Kevin A. Adamzek

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Valeria G. Nicolini

  • Roche Innovation Center Zurich

External person

David Wittig

  • Roche Innovation Center Zurich

External person

Umberto Maria Battisti

  • University of Copenhagen

External person

Ann Hoeben

  • Maastricht University Medical Center
  • Maastricht University

External person

Mary Birchler

  • GSK, 19426 Collegeville, United States

External person

Gerrit-Jan Liefers

  • Department of Surgery, Leiden, Netherlands

External person

Zuriñe Baz

  • CIC biomaGUNE

External person

Andor W. J. M. Glaudemans

  • University of Groningen

External person

Senthil Palani

  • University of Turku

External person

Elisabetta Vegeto

  • International Centre for Rural Health of the San Paolo Hospital

External person

D. Leung

  • Bristol-Myers Squibb

External person

Annelaure Damont

  • University of Paris

External person

Monica Paravidino

  • Vrije Universiteit Amsterdam

External person

Mariska Verlaan

  • VU University
  • Amsterdam UMC

External person

Daniel Padro

  • CIC biomaGUNE

External person

Pablo Umaña

  • Roche Innovation Center Zurich

External person

Carla M L van Herpen

  • Radboud University Medical Center
  • Radboud University Nijmegen

External person

Anna M. Planas

  • August Pi i Sunyer Biomedical Research Institute

External person

O. van Tellingen

  • Netherlands Cancer Institute

External person

J. Chris Slootweg

  • Vrije Universiteit Amsterdam

External person

Torsten Dreier

  • Argenx
  • AgomAb Therapeutics NV, 9000, Ghent, Belgium

External person

María M. Caffarel

  • Instituto de Investigación Sanitaria Biodonostia
  • Basque Foundation for Science

External person

Tanja Eichelsheim

  • Vrije Universiteit Amsterdam

External person

David R. Bonsall

  • Invicro LLC, London, UK

External person

Uta Funke

  • Department of Radiology and Nuclear Medicine
  • VU University Medical Centre
  • Pharmaceutical Analysis
  • KU Leuven
  • Vrije Universiteit Amsterdam

External person

Beatrice Longo

  • University of Aberdeen
  • Loughborough University

External person

Sang We Kim

  • University of Ulsan

External person

Inja Waldhauer

  • Roche Innovation Center Zurich

External person

Guy Bormans

  • Pharmaceutical Analysis
  • KU Leuven

External person

Heidi Liljenbäck

  • University of Turku

External person

Marion M. Deken

  • Leiden University

External person

Javier Calvo

  • CIC biomaGUNE

External person

Bastian Zinnhardt

  • University of Münster

External person

Palle Christophersen

  • Saniona A/S, Ballerup, Denmark

External person

Winette T. A. van der Graaf

  • Radboud University Medical Center
  • Royal Marsden NHS Foundation Trust
  • Institute of Cancer Research
  • University Medical Center Groningen
  • Netherlands Cancer Institute
  • Erasmus Universiteit Rotterdam

External person

Shane M. Wilkinson

  • University of Sydney
  • School of Chemistry

External person

Samuel Moser

  • Roche Innovation Center Zurich

External person

Maria Cristina de Vera Mudry

  • F. Hoffmann-La Roche AG

External person

S.G. Elias

  • Julius Health Care Centers

External person

Olga Hamming-Vrieze

  • Netherlands Cancer Institute

External person

Ludwig Aigner

  • Paracelsus Private Medical University

External person

Andreas Jacobs

  • University of Münster

External person

Alexander L. Vahrmeijer

  • LUMC
  • Leiden University

External person

Chris Klaver

  • Vrije Universiteit Amsterdam

External person

Pekka Taimen

  • University of Turku

External person

James O’Brien-Brown

  • School of Chemistry, Sydney, Australia

External person

J. D.M. Herscheid

  • Location Radionuclidecenter
  • Vrije Universiteit Medical Center
  • Vrije Universiteit Amsterdam

External person

Sandra Laner-Plamberger

  • Paracelsus Private Medical University

External person

Anu J. Airaksinen

  • University of Helsinki
  • VU Medisch Centrum
  • Vrije Universiteit Medical Center

External person

Amina Ahbari

  • Department of Radiology and Nuclear Medicine

External person

Sabine Lang

  • Roche Innovation Center Zurich

External person

Cristina Mari

  • University of Zurich

External person

Kristen K. Skarratt

  • University of Sydney

External person

Massimiliano Baldassarre

  • University of Aberdeen

External person

Mary Ann Lukas

  • GlaxoSmithKline

External person

Anh Nguyên Nhât Hoàng

  • Elysia Raytest, Rue du Sart-Tilman 375, Liège, 4031, Belgium
  • University of Liège

External person

Thomas Hofer

  • Roche Innovation Center Zurich

External person

Simon G. Williams

  • Genentech Incorporated

External person

Shuyan Du

  • Bristol-Myers Squibb

External person

Chiara Zanato

  • University of Aberdeen

External person

David Thonon

  • Elysia Raytest, Rue du Sart-Tilman 375, Liège, 4031, Belgium

External person

Koop Lammertsma

  • Vrije Universiteit Amsterdam
  • University of Johannesburg

External person

Bert Van het Hof

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Bimbisar Desai

  • University of Graz

External person

Kim M Smits

  • Maastricht UMC
  • Maastricht University

External person

Frédéric Dollé

  • University of Paris

External person

Zhibo Liu

  • Peking University

External person

Rachel Scheffelaar

  • Vrije Universiteit Amsterdam

External person

Dieter Ory

  • Pharmaceutical Analysis
  • KU Leuven

External person

James Storey

  • GlaxoSmithKline

External person

Jan H M Schellens

  • Netherlands Cancer Institute
  • Utrecht University
  • Slotervaart Hospital

External person

Ingo H. Gorr

  • F. Hoffmann-La Roche AG

External person

Rodney H. Falk

  • Brigham and Women's Hospital

External person

Sylvie Chalon

  • Université de Tours

External person

Kristina Herfert

  • University of Tübingen

External person

Ernst-Jan Speel

  • Maastricht University

External person

Lisa A. Wells

  • Invicro LLC, London, UK

External person

Paolo Gelosa

  • IRCCS Centro Cardiologico S.P.A. Fondazione Monzino - Milano

External person

Christian Gerdes

  • Roche Innovation Center Zurich

External person

Emilie M.J. van Brummelen

  • Netherlands Cancer Institute
  • Centre for Human Drug Research
  • Antoni Van Leeuwenhoek Hospital

External person

Paolo Michieli

  • AgomAb Therapeutics NV, 9000, Ghent, Belgium
  • University of Turin

External person

Anass Znabet

  • Vrije Universiteit Amsterdam

External person

Eero Hippeläinen

  • University of Helsinki

External person

Cornelis van de Velde

  • Leiden University

External person

Alejandro Pitarch

  • Boehringer Ingelheim International GmbH

External person

Helen Millns

  • GlaxoSmithKline

External person

Cristina Simó

  • CIC biomaGUNE

External person

Jennifer A. Ong

  • University of Sydney

External person

Alexander Peltzer

  • Boehringer Ingelheim Pharma GmbH & Co. KG Biberach

External person

Ian Schneider

  • GlaxoSmithKline
  • Consolidated Consulting LTD

External person

Rob M.J. Liskamp

  • Utrecht University

External person

Paul Trevorrow

  • Wiley, Chichester, UK

External person

Adriana di Nanni

  • University of Tübingen

External person

Marie Davies

  • GlaxoSmithKline

External person

Zhi Yang

  • Shanghai Mental Health Center, China
  • Peking University Cancer Hospital

External person

Firdaouss Boutkourt

  • Vrije Universiteit Amsterdam

External person

Chris Matheny

  • Oncology R and D, King of Prussia, United States

External person

Adam McGeoch

  • Division of Experimental Medicine and Immunotherapeutics, Cambridge, United Kingdom

External person

Andreas Maurer

  • University of Tübingen

External person

Jens Sörensen

  • Uppsala University

External person

Federica Bonanno

  • University of Tübingen

External person

E. T. Wünsche

  • Vrije Universiteit Amsterdam

External person

Maxwell W. G. Miner

  • University of Turku

External person

Lenka M. Pereira Arias-Bouda

  • Leiden University
  • Department of Nuclear Medicine, Leiderdorp, Netherlands

External person

Oliver Ast

  • Roche Innovation Center Zurich

External person

David J. Donnelly

  • Bristol-Myers Squibb

External person

Ekkehard Moessner

  • Roche Innovation Center Zurich

External person

Christophe Borg

  • Centre Hospitalier Universitaire Besançon

External person

Zahi A. Fayad

  • Icahn School of Medicine at Mount Sinai
  • Zena and Michael A. Wiener Cardiovascular Institute

External person

Gregory David Bowden

  • University of Tübingen

External person

E. M. C. Voormolen

  • Leiden University

External person

Duncan Richards

  • GlaxoSmithKline
  • University of Oxford

External person

Mats Bergström

  • GlaxoSmithKline

External person

Douglas Thompson

  • GlaxoSmithKline

External person

Anke Van Der Perren

  • Neurobiology and Gene Therapy
  • KU Leuven

External person

Jean Dasilva

  • Université de Montréal

External person

Jean N. DaSilva

  • Université de Montréal

External person

Robin S. Bon

  • Vrije Universiteit Amsterdam

External person

A. W. Ehlers

  • Vrije Universiteit Amsterdam
  • University of Johannesburg

External person

Rob Hanssen

  • Cristal Therapeutics

External person

Kepa B. Uribe

  • CIC biomaGUNE

External person

Jenni Virta

  • University of Turku

External person

Ruth G. Keijsers

  • Radboud University Nijmegen

External person

Charles H. Lawrie

  • Instituto de Investigación Sanitaria Biodonostia
  • Basque Foundation for Science
  • University of Oxford

External person

Dominik Ruettinger

  • Roche Innovation Center Munich

External person

Hyojin Cha

  • Sogang University

External person

Dae Yoon Chi

  • Sogang University

External person

Mariska Verlaan

  • Amsterdam UMC
  • University of Amsterdam

External person

Sjoerd G Elias

  • Utrecht University

External person

Erwin van Puijenbroek

  • Roche Innovation Center Zurich

External person

Ibai E. Valverde

  • University of Basel

External person

C. M. L. van Herpen

  • Radboud University Nijmegen

External person

Toma N. Glasnov

  • University of Graz

External person

Anne Roivainen

  • University of Turku

External person

Martin N. Wasser

  • Leiden University

External person

C. Oliver Kappe

  • University of Graz

External person

Riikka Viitanen

  • University of Turku

External person

Eryn L. Werry

  • University of Sydney

External person

Ellen Doeleman

  • Amsterdam UMC (location VUmc), Amsterdam, Netherlands

External person

Helen Jansen

  • Vrije Universiteit Amsterdam

External person

Sirpa Jalkanen

  • University of Turku

External person

Unai Cossío

  • CIC biomaGUNE

External person

Alexandra Winkeler

  • University of Paris

External person

Matt Szapacs

  • GSK, 19426 Collegeville, United States

External person